All Regulation articles – Page 21
-
BusinessIndustry weighs in on Nafta rewrite
Canadian, Mexican and US trade bodies united in call for more unified regulation in new trade deal
-
OpinionHow much is your chief executive worth?
The executive pay and equality debate is here to stay
-
OpinionDrug regulation is a burden worth bearing
Calls to break down regulatory barriers show a misunderstanding of the industry
-
NewsTrump’s health secretary faces conflict of interest allegations
Tom Price accused of abusing his office to favour companies in which he invested
-
NewsBPA added to ‘very high concern’ list of substances in EU
Decision by the European Chemicals Agency could ultimately lead to a ban on the chemical’s use
-
NewsFDA inspection data on nearly 1,000 overseas drug firms is missing
80% of US drug ingredients now come from abroad, yet challenges remain in FDA oversight of foreign drug firms
-
NewsVolkswagen hit by another $4.3bn in penalties
Emissions cheating scandal has led to the arrest of six senior employees at the company, just as Fiat comes under fire
-
NewsObama’s science legacy: rhetoric versus reality
Outgoing US president was a great spokesperson for science, but wasn’t able to translate that zeal into budget boosts
-
BusinessShell fined $22m for drinking water contamination
Jury rules in favour of US city of Clovis over 1,2,3-trichloropropane contamination, while rejecting punitive damages
-
BusinessIndian court revokes ban on combination drugs
Companies claim government failed to follow procedure in restricting risky medicines
-
ResearchLow level manganese fumes ups welders' Parkinson’s risk
The greater the exposure of welders to airborne manganese, the more quickly symptoms of Parkinson’s disease progress
-
-
BusinessSyngenta subsidiary faces fine over pesticide exposure
US environment agency wants firm to pay $5 million after workers hospitalised after coming into contact with chlorpyrifos
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
BusinessDeath sentence for head of Tianjin explosion firm
48 Ruihai Logistics staff and government officials also sentenced
-
OpinionHow to make Reach risk assessments more transparent
Chemical safety data is still hard to access because of the ECHA’s own rules
-
Business£90m fine for Pfizer and Flynn Pharma over excessive drug pricing
Markets watchdog imposes record fine for breaches of competition law
-
NewsHealth agency calls for ban on neonicotinoid in Canada
Government body reports imidacloprid poses a threat to marine insects and soil-dwelling organisms
-
NewsHomeopathic ‘medicines’ will have to state they don’t work
US trade agency will require packaging and adverts to state there is no scientific evidence to back up claims of efficacy
-
OpinionUncertainty around Trump presidency is harmful to industry
Uncertainty is anathema to industry. Trump and Brexit are frustrations, but the wheels do not stop.